LeMaitre Vascular, Inc. (LMAT) DCF Valuation

Lemaitre Vascular, Inc. (LMAT) Valoración de DCF

US | Healthcare | Medical - Instruments & Supplies | NASDAQ
LeMaitre Vascular, Inc. (LMAT) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

LeMaitre Vascular, Inc. (LMAT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Lemaitre Vascular, Inc. (LMAT) con esta calculadora DCF personalizable! Con Real Lemaitre Vascular, Inc. (LMAT) financieras y entradas de pronóstico ajustable, puede probar escenarios y descubrir Lemaitre Vascular, Inc. (LMAT) valor razonable en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 117.2 129.4 154.4 161.7 193.5 219.6 249.4 283.1 321.4 364.8
Revenue Growth, % 0 10.35 19.37 4.68 19.69 13.52 13.52 13.52 13.52 13.52
EBITDA 27.1 36.9 46.0 36.9 49.0 56.9 64.6 73.4 83.3 94.5
EBITDA, % 23.11 28.52 29.78 22.84 25.32 25.91 25.91 25.91 25.91 25.91
Depreciation 5.4 8.2 9.5 9.4 9.5 12.2 13.9 15.8 17.9 20.3
Depreciation, % 4.62 6.36 6.14 5.84 4.92 5.57 5.57 5.57 5.57 5.57
EBIT 21.7 28.7 36.5 27.5 39.5 44.7 50.7 57.6 65.4 74.2
EBIT, % 18.49 22.16 23.64 17.01 20.4 20.34 20.34 20.34 20.34 20.34
Total Cash 32.7 27.0 70.0 82.7 105.1 87.6 99.5 112.9 128.2 145.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 16.6 19.6 19.6 22.0 25.1
Account Receivables, % 14.14 15.11 12.71 13.63 12.95
Inventories 39.5 45.1 46.1 50.3 52.3 68.8 78.1 88.7 100.6 114.3
Inventories, % 33.72 34.87 29.86 31.1 27.05 31.32 31.32 31.32 31.32 31.32
Accounts Payable 2.6 2.4 2.3 2.9 3.7 4.1 4.6 5.3 6.0 6.8
Accounts Payable, % 2.22 1.85 1.52 1.8 1.93 1.86 1.86 1.86 1.86 1.86
Capital Expenditure -3.8 -3.0 -4.9 -3.2 -7.3 -6.3 -7.2 -8.2 -9.3 -10.5
Capital Expenditure, % -3.21 -2.31 -3.16 -2 -3.75 -2.89 -2.89 -2.89 -2.89 -2.89
Tax Rate, % 23.74 23.74 23.74 23.74 23.74 23.74 23.74 23.74 23.74 23.74
EBITAT 17.9 22.2 28.6 20.6 30.1 34.9 39.6 44.9 51.0 57.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -33.9 18.7 32.1 20.8 28.1 19.6 33.5 38.0 43.1 48.9
WACC, % 8.58 8.58 8.58 8.58 8.58 8.58 8.58 8.58 8.58 8.58
PV UFCF
SUM PV UFCF 139.5
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 51
Terminal Value 1,111
Present Terminal Value 736
Enterprise Value 876
Net Debt -5
Equity Value 881
Diluted Shares Outstanding, MM 22
Equity Value Per Share 39.29

What You Will Receive

  • Genuine LeMaitre Data: Preloaded financial metrics – encompassing revenue to EBIT – derived from actual and projected statistics.
  • Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on LeMaitre's fair value.
  • Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth forecasting.
  • Efficient and Precise: Eliminate the need to build models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive Financial Data: LeMaitre Vascular’s historical financial statements and pre-filled forecasts.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Insights: Observe LeMaitre Vascular’s intrinsic value recalculating instantly.
  • Intuitive Visualizations: Dashboard charts present valuation results and essential metrics clearly.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-built Excel file containing LeMaitre Vascular, Inc.'s (LMAT) financial data.
  • Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose This Calculator for LeMaitre Vascular, Inc. (LMAT)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your financial analysis needs.
  • Real-Time Valuation: Observe immediate updates to LeMaitre’s valuation as you modify inputs.
  • Preloaded Data: Comes with LeMaitre’s actual financial figures for swift evaluations.
  • Relied Upon by Experts: Trusted by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for analyzing investments in the medical device sector.
  • Corporate Finance Teams: Evaluate financial scenarios to support strategic decision-making within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for LeMaitre Vascular, Inc. (LMAT) to clients in the healthcare industry.
  • Students and Educators: Utilize real-world data to enhance learning and teaching of financial modeling techniques.
  • Medical Device Enthusiasts: Gain insights into how companies like LeMaitre Vascular, Inc. (LMAT) are valued in the healthcare market.

What the Template Contains

  • Preloaded LMAT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.